Jag Capital Management LLC Acquires 4,954 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Jag Capital Management LLC increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 9.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,086 shares of the biotechnology company's stock after buying an additional 4,954 shares during the quarter. Axon Enterprise comprises 2.7% of Jag Capital Management LLC's portfolio, making the stock its 13th largest holding. Jag Capital Management LLC owned about 0.07% of Axon Enterprise worth $22,412,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in AXON. Envestnet Portfolio Solutions Inc. grew its holdings in Axon Enterprise by 11.8% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 4,468 shares of the biotechnology company's stock worth $1,398,000 after buying an additional 471 shares in the last quarter. Empowered Funds LLC acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at $340,000. Oppenheimer & Co. Inc. lifted its position in shares of Axon Enterprise by 5.1% during the 1st quarter. Oppenheimer & Co. Inc. now owns 3,802 shares of the biotechnology company's stock valued at $1,190,000 after acquiring an additional 183 shares during the last quarter. Concurrent Investment Advisors LLC acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at $216,000. Finally, Sei Investments Co. lifted its holdings in shares of Axon Enterprise by 24.4% in the first quarter. Sei Investments Co. now owns 117,938 shares of the biotechnology company's stock valued at $36,901,000 after purchasing an additional 23,148 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on AXON. Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a report on Monday. Craig Hallum upped their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a "buy" rating in a research note on Wednesday, August 7th. Bank of America began coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a "buy" rating and a $380.00 price target on the stock. JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a research note on Thursday, October 31st. Finally, Robert W. Baird upped their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an "outperform" rating in a research note on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $427.83.

Axon Enterprise Stock Up 2.1 %

Axon Enterprise stock traded up $12.96 during mid-day trading on Monday, hitting $616.14. 1,789,865 shares of the company's stock were exchanged, compared to its average volume of 544,215. The stock has a market cap of $46.56 billion, a P/E ratio of 158.14, a P/E/G ratio of 15.15 and a beta of 0.94. The stock has a 50 day moving average of $414.16 and a two-hundred day moving average of $347.59. Axon Enterprise, Inc. has a 1-year low of $216.73 and a 1-year high of $624.84. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35.

Insider Activity

In other news, CFO Brittany Bagley sold 4,338 shares of the firm's stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $378.95, for a total value of $1,643,885.10. Following the sale, the chief financial officer now directly owns 98,825 shares of the company's stock, valued at approximately $37,449,733.75. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total value of $1,643,885.10. Following the completion of the sale, the chief financial officer now owns 98,825 shares in the company, valued at approximately $37,449,733.75. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total transaction of $167,863.50. Following the completion of the sale, the director now owns 7,379 shares of the company's stock, valued at approximately $2,752,588.37. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 369,172 shares of company stock valued at $136,270,842. 6.10% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.